Pancreas and cystic fibrosis: The implications of increased survival in cystic fibrosis

Pancreatology

Volumn 7, Issue 5-6, 2007, Pages 447-450

  Krysa, J ^a   Steger, A ^a  

^a UNIVERSITY HOSPITAL LEWISHAM   (United Kingdom)

Author keywords

Cystic fibrosis; Pancreas; Pancreatic cancer; Pancreatitis

Indexed keywords

TRANSMEMBRANE CONDUCTANCE REGULATOR; TRYPSINOGEN;

CANCER INCIDENCE; CANCER RISK; CANCER SURVIVAL; CYSTIC FIBROSIS; DISEASE COURSE; GENE FREQUENCY; GENE MUTATION; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG TRANSPLANTATION; NONHUMAN; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREAS INSUFFICIENCY; PANCREATITIS; PREVALENCE; PRIORITY JOURNAL; REVIEW; SCREENING TEST; SMOKING CESSATION;

EID: 35348864461     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000108961     Document Type: Article

References (28)

1. Cyr DM: Arrest of CFTRDeltaF508 folding. Nat Struct Mol Biol 2005;12:2-3.
2. Lamprecht G, Mau UA, Kortum C, Raible A, Stern M, Riess O, Gregor M: Relapsing pancreatitis due to a novel compound heterozygosity in the CFTR gene involving the second most common mutation in central and eastern Europe [CFTRdele2,3(21 kb)]. Pancreatology 2005;5:92-96.
3. Reddy MM, Quinton PM: Control of dynamic CFTR selectivity by glutamate and ATP in epithelial cells. Nature 2003;423:756-760.
4. Cystic Fibrosis Foundation, Patient Registry 2002 Annual Report, Maryland (www.cff.org).
5. Krysa J, Luce P, Steger A: The relationship between cystic fibrosis and pancreatitis (abstract). Pancreatology 2005;5:101.
6. Goldacre MJ, Roberts SE: Hospital admission for acute pancreatitis in an English population, 1963-98: database study of incidence and mortality. BMJ 2004;328:1466-1469.
7. Shwachman H, Lebenthal E, Khaw K-T: Recurrent acute pancreatitis in patients with cystic fibrosis with normal pancreatic enzymes. Pediatrics 1975;55:86-94.
8. Durno C, Corey M, Zielensky J, Tullis E, Tsui L-C, Durie P: Genotype and phenotype correlations in patients with cystic fibrosis and pancreatitis. Gastroenterology 2002;123:1857-1864.
9. De Boeck K, Weren M, Proesmans M, Kerem E: Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype. Pediatrics 2005;115:e463-e469.
10. Nagar AB, Gorelick FS: Acute pancreatitis. Curr Opin Gastroenterol 2004;20:439-443.
11. Mastella G, Zanolla L, Castellani C, Altieri S, Furnari M, Giglio L, Lombardo M, Miano A, Sciuto C, Pardo F, Magazzù G: Neonatal screening for cystic fibrosis: long-term clinical balance. Pancreatology 2001;1:531-537.
12. Durie PR, Forstner GG, Gaskin KJ, Moore DJ, Cleghorn GJ, Wong SS, Corey ML: Age-related alterations of immunoreactive pancreatic cationic trypsinogen in sera from cystic fibrosis patients with and without pancreatic insufficiency. Pediatr Res 1986;20:209-213.
13. Durie PR, Largman C, Brodrick JW, Johnson JH, Gaskin KJ, Forstner GG, Geokas MC: Plasma immunoreactive pancreatic cationic trypsinogen in cystic fibrosis: a sensitive indicator of exocrine pancreatic dysfunction. Pediatr Res 1981;15:1351-1355.
14. Couper RT, Corey M, Durie PR, Forstner GG, Moore DJ: Longitudinal evaluation of serum trypsinogen measurement in pancreatic insufficient and pancreatic sufficient patients with cystic fibrosis. J Pediatr 1995;127:408-413.
15. Sarles J, Barthellemy S, Ferec C, Iovanna J, Roussey M, Farriaux JP, Toutain A, Berthelot J, Maurin N, Codet JP, Berthezene P, Dagorn JC: Blood concentrations of pancreatitis-associated protein in neonates: relevance to neonatal screening for cystic fibrosis. Arch Dis Child Fetal Neonatal Ed 1999;80:F118-F122.
16. Durie PR: Pancreatitis and mutations of the cystic fibrosis gene. N Engl J Med 1998;339:687-688.
17. Welsh M, Smith A: Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell 1993;73:1251-1254.
18. Lowenfels AB, Maisonneuve P, Cavallini G, Ammann RW, Lankisch PG, et al: Pancreatitis and the risk of pancreatic cancer. N Engl J Med 1993;328:1433-1437.
19. Whitcombe DC, Pogue-Geile K: Pancreatitis as a risk for pancreatic cancer. Gastroenterol Clin North Am 2002;31:663-678.
20. Whitcomb DC: Inflammation and cancer. V. Chronic pancreatitis and pancreatic cancer. Am J Physiol 2004;287:G315-G319.
21. Stead RJ, Redington AN, Hinks LJ, Clayton BE, Hodson ME, Batten JC: Selenium deficiency and possible increased risk of carcinoma in adults with cystic fibrosis. Lancet 1985;2:862-863.
22. Sheldon CD, Hodson ME, Carpenter LM, Swerdlow AJ: A cohort study of cystic fibrosis and malignancy. Br J Cancer 1993;68:1025-1028.
23. Neglia JP, FitzSimmons SC, Maisonneuve P, Schoni MH, Schoni-Affolter F, Corey M, Lowenfels AB: The risk of cancer among patients with cystic fibrosis. Cystic Fibrosis and Cancer Study Group. N Engl J Med 1995;332:494-499.
24. Wood HE, Gupta S, Kang JY, Quinn MJ, Maxwell JD, Mudan S, Majeed A: Pancreatic cancer in England and Wales 1975-2000: patterns and trends in incidence, survival and mortality. Aliment Pharmacol Ther 2006;23:1205-1214.
25. Petrowsky H, Schuster H, Irani S, Schafer M, Jochum W, Schmid C, Boehler A, Clavien PA: Pancreatic cancer in cystic fibrosis after bilateral lung transplantation. Pancreas 2006;33:430-432.
26. Daftary A, Acton J, Heubi J, Amin R: Fecal elastase-1: utility in pancreatic function in cystic fibrosis. J Cyst Fibros 2006;5:71-76.
27. Vitone LJ, Greenhalf W, McFaul CD, Ghaneh P, Neoptolemos JP: The inherited genetics of pancreatic cancer and prospects for secondary screening. Best Pract Res Clin Gastroenterol 2006;20:253-283.
28. Schneider A, Pfutzer R, Whitcomb DC: Genetics and pancreatic disease. Curr Opin Gastroenterol 2002;18:545-551.